Table 3.

Comparison of clinical and laboratory indices in patients who recovered or died

Index	Death	Recovery (discharge)	p
NEWS2 baseline	n=11; 9 (8:10)	n=63; 4 (3:5)	<0.001*
NEWS2, after TCZ	n=11 9 (8:9)	n=63 2 (1:3)	<0.001*
CRP mg/L baseline	n=11 168 (77:205)	n=63 94 (33:148)	NSD
CRP mg/L, after TCZ	n=11 51 (23:153)	n=63 13 (5:23)	0.001
Lymphocytes/uL baseline	n=11 600 (500:700)	n=63 900 (700:1200)	0.003
Lymphocytes/uL, after TCZ	n=11 800 (350:1100)	n=63 1100 (850:1400)	0.05

Presented are clinical and laboratory indices at baseline (just before TCZ administration) and one-to-two days after TCZ treatment in patients who died and patients who survived to discharge from hospital. Number of patients (n) and interquartile ranges (IQR) are presented. NSD -no statistical differences Data for total of 74 patients. Another 15 patients remain in hospital, at time of writing.